Abstract
We have studied the structure and function of Human Misshapen / NIK-related kinase (MINK-1)through a combination of computational methods and experimental approaches,including (1)fold recognition and sequence-structure alignment for each structural domain using the threading program PROSPECT,(2)gene expression and protein-protein interaction analysis of yeast homologs of human MINK-1 domains,and (3)yeast two-hybrid screening for proteins that interact with human MINK-1.Our structure prediction dissects MINK-1 into four domains:a conserved N-terminal kinase domain,followed by a coiled-coil region and a proline-rich region,and a C- terminal GCK domain.Gene expression and yeast two-hybrid analysis of yeast homologs of the MINK-1 domains suggest that MINK-1 may be involved in cell-cycle progression and cytoskeletal control.Consistent with these predicted functions,our in-house yeast two-hybrid screen for proteins that interact with human MINK-1 provides strong evidence that the coiled-coil and proline-rich domains of MINK-1 participate in the regulation of cytoskeletal organization,cell-cycle control and apoptosis.A homology model of the MINK-1 kinase domain was used to screen the NCI open compound database in DOCK,and chemical compounds with pharmaceutically acceptable properties were identified.Further medicinal chemistry compound structure optimization and kinase assays are underway.
Keywords: mink, ste20-related kinases, gck domain, signal transduction, protein structure prediction, threading, yeast two-hybrid, gene expression, docking
Current Medicinal Chemistry
Title: Computational and Experimental Studies on Human Misshapen / NIK- Related Kinase MINK-1
Volume: 11 Issue: 5
Author(s): Kunbin Qu, Yanmei Lu, Nan Lin, Rajinder Singh, Xiang Xu, Donald G. Payan and Dong Xu
Affiliation:
Keywords: mink, ste20-related kinases, gck domain, signal transduction, protein structure prediction, threading, yeast two-hybrid, gene expression, docking
Abstract: We have studied the structure and function of Human Misshapen / NIK-related kinase (MINK-1)through a combination of computational methods and experimental approaches,including (1)fold recognition and sequence-structure alignment for each structural domain using the threading program PROSPECT,(2)gene expression and protein-protein interaction analysis of yeast homologs of human MINK-1 domains,and (3)yeast two-hybrid screening for proteins that interact with human MINK-1.Our structure prediction dissects MINK-1 into four domains:a conserved N-terminal kinase domain,followed by a coiled-coil region and a proline-rich region,and a C- terminal GCK domain.Gene expression and yeast two-hybrid analysis of yeast homologs of the MINK-1 domains suggest that MINK-1 may be involved in cell-cycle progression and cytoskeletal control.Consistent with these predicted functions,our in-house yeast two-hybrid screen for proteins that interact with human MINK-1 provides strong evidence that the coiled-coil and proline-rich domains of MINK-1 participate in the regulation of cytoskeletal organization,cell-cycle control and apoptosis.A homology model of the MINK-1 kinase domain was used to screen the NCI open compound database in DOCK,and chemical compounds with pharmaceutically acceptable properties were identified.Further medicinal chemistry compound structure optimization and kinase assays are underway.
Export Options
About this article
Cite this article as:
Qu Kunbin, Lu Yanmei, Lin Nan, Singh Rajinder, Xu Xiang, Payan G. Donald and Xu Dong, Computational and Experimental Studies on Human Misshapen / NIK- Related Kinase MINK-1, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455873
DOI https://dx.doi.org/10.2174/0929867043455873 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Subject Index To Volume 2
Current Drug Targets Interferon: Cellular Executioner or White Knight?
Current Medicinal Chemistry Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes
Cardiovascular & Hematological Disorders-Drug Targets Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View
Current Molecular Medicine Transbronchial Needle Aspiration (TBNA): Past Present and Future
Current Respiratory Medicine Reviews Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide
Current Drug Metabolism Organophosphorus Compounds: Intervention in Mechanisms of Signal Transduction Relevant to Proliferative, Immunological and Circulatory Disorders
Current Medicinal Chemistry The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
Current Cancer Drug Targets Editorial [Hot Topic: Recombinant Immunotoxins – The Next Generation (Executive Editor: Stefan Barth)]
Current Pharmaceutical Design Curcuminoid Metabolism and its Contribution to the Pharmacological Effects
Current Drug Metabolism Editorial [Hot Topic: Nutraceuticals and Prevention of Neurodegeneration (Executive Guest Editors: Thea Magrone and Emilio Jirillo)]
Current Pharmaceutical Design Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
Current Signal Transduction Therapy 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
Current Drug Discovery Technologies Recent Patents and Patent Applications Relating to mTOR Pathway
Recent Patents on DNA & Gene Sequences Etoposide, Topoisomerase II and Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Selective Cytotoxic Effects of 5-Trifluoromethoxy-<i>1H</i>-indole-2,3-dione 3-Thiosemicarbazone Derivatives on Lymphoid-originated Cells
Anti-Cancer Agents in Medicinal Chemistry Interferon Therapy for Malignant Solid Tumors
Current Drug Therapy Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Current Stem Cell Research & Therapy Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy